Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
The British Journal of Ophthalmology|October 13, 2006
Clinical features of dysthyroid optic neuropathy: a European Group on Graves' Orbitopathy (EUGOGO) surveyDavid McKeag, Carol Lane, John H Lazarus, et al.
The Journal of Clinical Endocrinology and Metabolism|July 26, 2013
Is thyroid cancer recurrence risk increased after transplantation?Hélène Tisset, Nassim Kamar, Isabelle Faugeron, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 21, 2025
Prospective Multicenter Evaluation of [<sup>11</sup>C]Methionine PET/MRI Sensitivity Compared with MRI for Localizing Small Pituitary Neuroendocrine Tumor or Pituitary Adenoma in Cushing DiseaseAnthime Flaus, Elise Levigoureux, Julie Haesebaert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 19, 2023
A Phase II Redifferentiation Trial with Dabrafenib-Trametinib and 131I in Metastatic Radioactive Iodine Refractory BRAF p.V600E-Mutated Differentiated Thyroid CancerSophie Leboulleux, Christine Do Cao, Slimane Zerdoud, et al.
The Journal of Clinical Endocrinology and Metabolism|July 26, 2013
One-year progression-free survival of therapy-naive patients with malignant pheochromocytoma and paragangliomaSégolène Hescot, Sophie Leboulleux, Laurence Amar, et al.
European Thyroid Journal|August 6, 2016
Recreational Physical Activity and Differentiated Thyroid Cancer Risk: A Pooled Analysis of Two Case-Control StudiesConstance Xhaard, Juan J Lence-Anta, Yan Ren, et al.
The New England Journal of Medicine|March 9, 2022
Thyroidectomy without Radioiodine in Patients with Low-Risk Thyroid CancerSophie Leboulleux, Claire Bournaud, Cecile N Chougnet, et al.
The Lancet. Diabetes & Endocrinology|November 25, 2024
Thyroidectomy without radioiodine in patients with low-risk thyroid cancer: 5 years of follow-up of the prospective randomised ESTIMABL2 trialSophie Leboulleux, Claire Bournaud, Cecile N Chougnet, et al.
Pageof 8